280 related articles for article (PubMed ID: 29662921)
21. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
Chaudhuri KR; Hand A; Obam F; Belsey J
J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
[TBL] [Abstract][Full Text] [Related]
22. Parkinson's Disease Progression and Statins: Hydrophobicity Matters.
Lewis MM; Albertson RM; Du G; Kong L; Foy A; Huang X
J Parkinsons Dis; 2022; 12(3):821-830. PubMed ID: 34958045
[TBL] [Abstract][Full Text] [Related]
23. Does MDS-UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease?
Tosin MHS; Stebbins GT; Comella C; Patterson CG; Hall DA;
Mov Disord Clin Pract; 2021 Oct; 8(7):1092-1099. PubMed ID: 34631945
[TBL] [Abstract][Full Text] [Related]
24. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
[TBL] [Abstract][Full Text] [Related]
25. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
[TBL] [Abstract][Full Text] [Related]
26. Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale.
Martínez-Martín P; Rodríguez-Blázquez C; Mario Alvarez ; Arakaki T; Arillo VC; Chaná P; Fernández W; Garretto N; Martínez-Castrillo JC; Rodríguez-Violante M; Serrano-Dueñas M; Ballesteros D; Rojo-Abuin JM; Chaudhuri KR; Merello M
Parkinsonism Relat Disord; 2015 Jan; 21(1):50-4. PubMed ID: 25466406
[TBL] [Abstract][Full Text] [Related]
27. Association of Structural Measurements of Brain Reserve With Motor Progression in Patients With Parkinson Disease.
Wang L; Wu P; Brown P; Zhang W; Liu F; Han Y; Zuo CT; Cheng W; Feng J
Neurology; 2022 Sep; 99(10):e977-e988. PubMed ID: 35667838
[TBL] [Abstract][Full Text] [Related]
28. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
[TBL] [Abstract][Full Text] [Related]
29. Modeling a Composite Score in Parkinson's Disease Using Item Response Theory.
Gottipati G; Karlsson MO; Plan EL
AAPS J; 2017 May; 19(3):837-845. PubMed ID: 28247193
[TBL] [Abstract][Full Text] [Related]
30. Socioeconomic Status May Impact Functional Outcome of Deep Brain Stimulation Surgery in Parkinson's Disease.
Genc G; Abboud H; Oravivattanakul S; Alsallom F; Thompson NR; Cooper S; Gostkowski M; Machado A; Fernandez HH
Neuromodulation; 2016 Jan; 19(1):25-30. PubMed ID: 26076401
[TBL] [Abstract][Full Text] [Related]
31. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Goetz CG; Fahn S; Martinez-Martin P; Poewe W; Sampaio C; Stebbins GT; Stern MB; Tilley BC; Dodel R; Dubois B; Holloway R; Jankovic J; Kulisevsky J; Lang AE; Lees A; Leurgans S; LeWitt PA; Nyenhuis D; Olanow CW; Rascol O; Schrag A; Teresi JA; Van Hilten JJ; LaPelle N
Mov Disord; 2007 Jan; 22(1):41-7. PubMed ID: 17115387
[TBL] [Abstract][Full Text] [Related]
32. Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.
Chahine LM; Siderowf A; Barnes J; Seedorff N; Caspell-Garcia C; Simuni T; Coffey CS; Galasko D; Mollenhauer B; Arnedo V; Daegele N; Frasier M; Tanner C; Kieburtz K; Marek K;
J Parkinsons Dis; 2019; 9(4):665-679. PubMed ID: 31450510
[TBL] [Abstract][Full Text] [Related]
33. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM;
JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
[TBL] [Abstract][Full Text] [Related]
34. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
[TBL] [Abstract][Full Text] [Related]
35. Predictive Value of Verbatim Parkinson's Disease Patient-Reported Symptoms of Postural Instability and Falling.
Javidnia M; Arbatti L; Hosamath A; Eberly SW; Oakes D; Shoulson I
J Parkinsons Dis; 2021; 11(4):1957-1964. PubMed ID: 34250951
[TBL] [Abstract][Full Text] [Related]
36. Probable REM Sleep Behavior Disorder Is a Risk Factor for Symptom Progression in Parkinson Disease.
Barasa A; Wang J; Dewey RB
Front Neurol; 2021; 12():651157. PubMed ID: 33897604
[No Abstract] [Full Text] [Related]
37. Intraoperative Quantification of MDS-UPDRS Tremor Measurements Using 3D Accelerometry: A Pilot Study.
Smid A; Elting JWJ; van Dijk JMC; Otten B; Oterdoom DLM; Tamasi K; Heida T; van Laar T; Drost G
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566401
[TBL] [Abstract][Full Text] [Related]
38. It Is as It Was: MDS-UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum.
Goetz CG; Choi D; Guo Y; Stebbins GT; Mestre TA; Luo S
Mov Disord; 2023 Feb; 38(2):342-347. PubMed ID: 36480107
[TBL] [Abstract][Full Text] [Related]
39. The glucocerebrosidase mutations and uric acid levels in Parkinson's disease: A 3-years investigation of a potential biomarker".
Mozafar M; Kazemian S; Hoseini E; Mohammadi M; Alimoghadam R; Shafie M; Mayeli M;
Clin Park Relat Disord; 2023; 8():100177. PubMed ID: 36590455
[TBL] [Abstract][Full Text] [Related]
40. Can Digital Mobility Assessment Enhance the Clinical Assessment of Disease Severity in Parkinson's Disease?
Kirk C; Zia Ur Rehman R; Galna B; Alcock L; Ranciati S; Palmerini L; Garcia-Aymerich J; Hansen C; Schaeffer E; Berg D; Maetzler W; Rochester L; Del Din S; Yarnall AJ
J Parkinsons Dis; 2023; 13(6):999-1009. PubMed ID: 37545259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
